Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR-Reference-Cited by-同舟云学术

Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR

Published:2019-03-18 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Dong Bin¹,Singh Amar¹,Guo Grace²,Young Mark³,Liu Jingwen¹

Affiliation:

1. Department of Veterans Affairs, Palo Alto Health Care System, Palo Alto, CA 94304, USA

2. Department of Pharmacology and Toxicology, School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA

3. Mistral Therapeutics, San Diego, CA 92121, USA

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion;Molecular Metabolism;2024-05

2. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-04-26

3. Mechanism for FXR to regulate bile acid and glycolipid metabolism to improve NAFLD;World Chinese Journal of Digestology;2023-10-08

4. Scavenger receptor-AI targeted theranostic nanoparticles for regression of atherosclerotic plaques via ABCA1 modulation;Nanomedicine: Nanotechnology, Biology and Medicine;2023-06

5. The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator;Frontiers in Pharmacology;2023-02-23